Radiosensitization by Cisplatin of RIF1 Tumour Cells in Vitro

References

• Alvarez V., Cobreros G., Heras A., Zumel C. Studies on cis-diamminedichloroplatinum (II) as a radiosensitizer. British Journal of Cancer 1978; 37(Suppl., 3)68–72
   Google Scholar
• Bartelink H., Kallman R.F., Rapachietta D., Hart G.A.M. The effects of radiation and cis-diamminedichloroplatinum (II) on tumor, skin and intestine in mice. Radiotherapy and Oncology 1986; 6: 61–74
   PubMedGoogle Scholar
• Bergerat J.P., Barlogie B., Drewinko B. Effects of cis-diamminedichloroplatinum (II) on human colon carcinoma cells in vitro. Cancer Research 1979; 39: 1334–1338
   PubMed Web of Science ®Google Scholar
• Carde P., Laval F. Effect of cis-diamminedichloroplatinum II and X-rays on mammalian cell survival. International Journal Radiation, Oncology, Biology, Physics 1981; 7: 929–933
   PubMed Web of Science ®Google Scholar
• Chibber R., Stratford I.J., O'Neill P., Sheldon P.W., Ahmed I., Lee B. The interaction between radiation and complexes of cis-Pt (II) and Rh (II): studies of the molecular and cellular level. International Journal Radiation Biology 1985; 48: 513–524
   Google Scholar
• Collard J.G., Smets L.A. Effect of proteolytic inhibitors on growth and surface architecture of normal and transformed cells. Experimental Cell Research 1974; 86: 75–80
   Google Scholar
• Douple E.B., Richmond R.C. A review of interactions between platinum coordination complexes and ionizing radiation: implications for cancer therapy. Cisplatin: Current Status and New Developments, A.W. Prestayko, S.T. Crooke, S.K. Carter. Academic Press, New York 1980; 125–147
   Google Scholar
• Drewinko B., Brown B.W., Gottlieb J.A. The effect of cis-diamminedichloroplatinum (II) on cultured human lymphoma cells and its therapeutic implications. Cancer Research 1973; 33: 3091–3095
   Google Scholar
• Dritschilo A., Piro A., Kelman A.D. The effect of cis-platinum on the repair of radiation damage in plateau phase Chinese hamster (V-79) cells. International Journal of Radiation, Oncology, Biology, Physics 1979; 5: 1345–1349
   PubMed Web of Science ®Google Scholar
• Ducore J.M., Erickson L.C., Zwelling L.A., Laurent G., Kohn K.W. Comparative studies of DNA cross-linking and cytotoxicity in Burkitt's lymphoma cell lines treated with cis-diamminedichloroplatinum (II) and l-phenylalanine mustard. Cancer Research 1982; 42: 897–902
   PubMedGoogle Scholar
• Evans R.G., Engel C., Wheatley C., Nielsen J. Modification of the sensitivity and repair of potentially lethal damage by diethyldithiocarbonate during and following exposure of plateau-phase cultures of mammalian cells to radiation and cis-diamminedichloroplatinum (II). Cancer Research 1982; 42: 3074–3078
   Google Scholar
• Fraval H.N.A., Roberts J.J. Effects of cis-platinum(II)diamminedichloride on survival and the rate of DNA synthesis in synchronously growing Chinese hamster V79-379 A cells in the absence and presence of caffeine inhibited post-replication repair; evidence for an inducible repair mechanism. Chemical Biological Interactions 1978; 23: 99–110
   Google Scholar
• Grdina D.J., Sigdestad C.P., Peters L.J. Cytotoxic effects in vivo of selected chemotherapeutic agents on synchronized murine fibrosarcoma cells. British Journal of Cancer 1980; 42: 677–683
   Google Scholar
• Harder H.C., Rosenberg B. Inhibitory effects of antitumor platinum compounds on DNA, RNA and protein synthesis in mammalian cells in vitro. International Journal of Cancer 1970; 6: 207–216
   PubMed Web of Science ®Google Scholar
• Herman T.S. Temperature dependence of adriamycin, cis-diamminedichloroplatinum, Bleomycin, and 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity in vitro. Cancer Research 1983; 43: 517–520
   PubMed Web of Science ®Google Scholar
• Jones A.C., Wilson P.A., Steel G.G. Cell survival in four ovarian carcinoma xenografts following in vitro exposure to melphalan, cisplatin and cis-diammine-1,1-cyclobutane dicarboxylate platinum II (CBDCA, JM8). Cancer Chemotherapy and Pharmacology 1984; 13: 109–113
   Google Scholar
• Lelieveld P., Scoles M.A., Brown J.M., Kallman R.F. The effect of treatment in fractionated schedules with the combination of X-irradiation and six cytotoxic drugs on the RIF1 tumor and normal mouse skin. International Journal of Radiation, Oncology, Biology, Physics 1985; 11: 111–121
   PubMedGoogle Scholar
• Meyn R.E., Meistrich M.L., White R.A. Cycle dependent anticancer drug cytotoxicity in mammalian cells synchronized by centrifugal elutriation. Journal of the National Cancer Institute 1980; 64: 1215–1219
   PubMedGoogle Scholar
• Meyn R.E., Jenkins S.F., Thompson L.H. Defective removal of DNA cross-links in a repair-deficient mutant of Chinese hamster cells. Cancer Research 1982; 42: 3106–3110
   Google Scholar
• Murthy A.K., Rossot A.H., Anderson K.M., Hendrickson F.R. Cytotoxicity and influence on radiation dose response curve of cis-diamminedichloroplatinum II (cis-DDP). International Journal of Radiation, Oncology, Biology, Physics 1979; 5: 1411–1415
   PubMedGoogle Scholar
• Pascoe J.M., Roberts J.J. Interactions between mammalian cell DNA and inorganic platinum compounds—II. Interstrand cross-linking of isolated and cellular DNA by platinum IV compounds. Biochemical Pharmacology 1974; 23: 1359–1365
   PubMed Web of Science ®Google Scholar
• Plooy A.C., Van Dijk M., Lohman P.H.M. Induction and repair of DNA cross-links in Chinese hamster ovary cells treated with various platinum coordination compounds in relation to platinum binding to DNA, cytotoxicity, mutagenicity, and antitumor activity. Cancer Research 1984; 44: 2043–2051
   PubMed Web of Science ®Google Scholar
• Poirier M.C., Lippard S.J., Zwelling L.A., Ushay H.M., Kerrigan D., Thill C.C., Santella R.M., Grunberger D., Yuspa S.H. Antibodies elicited against cis-diamminedichloroplatinum (II)—modified DNA are specific for cis-diamminedichloroplatinum (II)—DNA adducts formed in vivo and in vitro. Proceedings of the National Academy of Sciences, U.S.A. 1982; 79: 6443–6447
   PubMedGoogle Scholar
• Roberts J.J., Fraval H.N.A. Repair of cis-platinum(II)diamminedichloride-induced DNA damage and cell sensitivity. Cisplatin: Current Status and New Developments, A.W. Prestayko, S.T. Crooke, S.K. Carter. Academic Press, New York 1980; 57–77
   Google Scholar
• Rosenberg B., Van Camp L., Krigas T. Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode. Nature 1965; 205: 6995–6999
   Google Scholar
• Rosenberg B., Van Camp L., Trosko J., Mansour V.H. Platinum compounds: a new class of potent antitumour agents. Nature 1969; 222: 385–386
   PubMed Web of Science ®Google Scholar
• Steel G.G., Peckham M.J. Exploitable mechanisms in combined radiotherapy—chemotherapy: the concept of additivity. International Journal of Radiation, Oncology, Biology, Physics 1979; 5: 85–91
   PubMed Web of Science ®Google Scholar
• Stewart D.J., Leavens M., Maor M., Teun L., Luma M., Bonura J., Caprioll R., Loo T.J., Benjamin R.S. Human central nervous system distribution of cis-DDP and use as a radiosensitizer in malignant brain tumors. Cancer Research 1982; 42: 2474–2479
   PubMed Web of Science ®Google Scholar
• Szumiel I., Nias A.H.W. Isobologram analysis of the combined effects of antitumour platinum complexes and ionizing radiation on mammalian cells. British Journal of Cancer 1980; 42: 292–296
   Google Scholar
• Tulp A., Collard J.G., Hart A.A., Aten J.A. A new unit gravity sedimentation chamber. Annals of Biochemistry 1980; 105: 246–256
   Google Scholar
• Twentyman P.R., Brown J.M., Gray J.W., Franko A.J., Scoles M.A., Kallman R.F. A new mouse tumor model system (RIF-1) for comparison of endpoint studies. Journal of the National Cancer Institute 1980; 64: 595–604
   PubMedGoogle Scholar
• Williams C.J. Platinum coordination complexes: a new class of anticancer agents. Recent Advances in Clinical Oncology, C.J. Williams, J.M.A. Whitehouse. Churchill Livingstone, Edinburgh, London 1982; 1: 71–81
   Google Scholar
• Zwelling L.A., Kohn K.W., Ross W.E., Ewig R.A.G., Anderson T. Kinetics of formation and disappearance of a DNA cross-linking effect in mouse leukemia L1210 cells treated with cis- and trans-diamminedichloroplatinum (II). Cancer Research 1978; 35: 1762–1768
   Google Scholar
• Zwelling L.A., Michaels S., Schwartz H., Dobson P., Kohn K.W. DNA cross-linking as an indicator of sensitivity and resistance of mouse L1210 leukemia to cis-diamminedichloroplatinum (II) and L-phenylalanine mustard. Cancer Research 1981; 41: 640–649
   PubMed Web of Science ®Google Scholar